Lizette Day
Family · San Antonio, TXNPI 1477891166
Payments from drug & device makers
Across 58 payments — averaging $83.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$392
- AstraZeneca$370
- Abbott$329
- Abiomed$286
- Kyowa Kirin, Inc.$241
- Lilly USA, LLC$234
- plus $3K from 26 others
What the payments were for
- Consulting fees$190%
- Food & beverage$4,801100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 3 | $392 |
| AstraZeneca | 3 | $370 |
| Abbott | 3 | $329 |
| Abiomed | 3 | $286 |
| Kyowa Kirin, Inc. | 2 | $241 |
| Lilly USA, LLC | 2 | $234 |
| Acadia Pharmaceuticals Inc | 2 | $220 |
| AbbVie | 3 | $210 |
| Si-bone, Inc. | 2 | $206 |
| Johnson & Johnson(2 entities) | 5 | $185 |
| Amgen | 4 | $174 |
| Inspire Medical Systems, Inc. | 1 | $150 |
| Silk Road Medical, Inc. | 1 | $143 |
| GSK | 3 | $140 |
| Jazz Pharmaceuticals Inc. | 1 | $125 |
| Genentech USA, Inc. | 1 | $125 |
| Axsome Therapeutics, Inc. | 1 | $124 |
| Bayer | 1 | $122 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $120 |
| Teva Pharmaceuticals USA, Inc. | 1 | $114 |
| Amarin Pharma, Inc. | 1 | $113 |
| Edwards Lifesciences | 1 | $109 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $106 |
| Lucid Diagnostics Inc. | 1 | $102 |
| Stemline Therapeutics Inc. | 1 | $98 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $80 |
| Galderma Laboratories, L.p. | 3 | $59 |
| Daiichi Sankyo Inc. | 2 | $46 |
| Coloplast | 1 | $39 |
| Organon | 1 | $21 |
| ADMA Biomanufacturing LLC | 1 | $19 |
| Tersera Therapeutics LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENROUTE Transcarotid Neuroprotection System$286
- OMVOH$234
- Inspire$150
- AMS 700$143
- ENROUTE Transcarotid Stent$143
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$143
- WATCHMAN FLX$142
- SPRAVATO$138
- SAPHNELO$125
- OCREVUS$125
- ZIIHERA$125
- AIRSUPRA$125
- Auvelity$124
- DAYBUE$122
- Kerendia$122
- EVENITY$122
- CRYSVITA$121
- FARXIGA$120
- NURTEC ODT$120
- Austedo XR$114
How this compares
$4,820 in reported general payments places this provider in the 90th percentile of 15,456 family providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family in San Antonio
- Anna CastroSan Antonio$184K
- Natalia FariasSan Antonio$124K
- Ayoade AvworoSan Antonio$111K
- Tina CoppleSan Antonio$97K
- Kim HinojosaSan Antonio$63K
- Kimberly GibergaSan Antonio$36K
- Lashonda CraneHouston$3.4M
- David WeirDallas$959K
- Luba YammineHouston$479K
- Robin BeachHouston$428K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.